- Category: Business
Business
Amaros secures Series A financing for AI ophthalmic evidence platform
Financing will support adoption and commercialization of the EvidenceEngine to accelerate clinical trial enrollment and generate real-world evidence on retinal disease.
Business
1-800 Contacts launches digital eyewear retail store
Online contact lens retailer debuts new frame and lens e-commerce shop with prescription integration, virtual and in-home try-ons, and cost-effective options.
Business
Pangaea Data's AI platform receives Topcon investment
Collaboration involves the PALLUX, which will analyze patient records against clinical guidelines and identify untreated and undiagnosed patients with ocular and systemic diseases.
Business
Therini Bio raises nearly $40M to study DME and Alzheimer's immunotherapeutics
Funding to support two trials on fibrin-targeting immunotherapies targeting vascular dysfunction-induced neuroinflammation in severe retinal and neurological diseases.
Business
Topcon invests in MedTech startup’s microdosing drug delivery system
Collaboration involves MistGo Digital, under clinical development as a drug delivery system combined with a digital adherence monitoring platform.
Business
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.
Business
Azalea Vision raises $9M to support development of intelligent ocular tech platform
Financing to support initiation of a FIH trial on the company’s smart contact lens platform; veteran ophthalmic leader appointed as chairman of the Board.
Business
Carl Zeiss Meditec AG CEO to step down
Dr. Markus Weber makes a surprise move by leaving the role at the end of May, with longtime ZEISS executive Maximilian Foerst named as successor.
Business
CORE Director Dr. Lyndon Jones to step down amid scope expansion
CORE announces integration plans into the Waterloo Eye Institute and the creation of a steering committee as it looks to expand into research of the vision system and beyond.
Business
Topcon names former Genentech exec as chief medical officer
Daniela Ferrara, MD, PhD’s role involves establishing retinal imaging as a first-line tool for both eyecare and the screening and management of complex systemic diseases.
Business
BVI Medical and Neurotech name new CCOs
With over 20 years of executive leadership experience each, Andrew Chang and Beth Marsh will lead commercialization efforts for their respective companies’ upcoming product launches.
Business
CSI Dry Eye Software selects new CEO
Eye care industry executive Ken Barbet takes the helm as the AI-based dry eye management platform seeks to help ECPs standardize and deliver customized treatment.
Business
CORE launches environmental-focused eyewear education website
SustainableEyecare.com offers a digital guide for ECPs and patients on solutions and programs for recycling contact lenses and other eyewear.
Business
Voiant acquires AI-based ophthalmic image analysis startup Voxeleron
Software and clinical trial expertise to combine into an AI-based integrated platform for retinal and corneal imaging, with a goal of expedited patient treatment delivery.
Business
Opthea to cut workforce by an estimated 65%
Significant layoffs follow in wake of the company's phase 3 trial failures and subsequent termination of its wet AMD program late last month.
Business
How will reciprocal tariffs impact the optical industry?
The Vision Council updates industry members as the U.S. imposes new 10% tariffs on 60+ countries across the globe—and 125% on China.
Business
Pantheon Vision and Eyedeal Medical to develop bioengineered corneal implant
Collaboration involves advancement and commercialization of Pantheon’s artificial cornea as the company nears a potential premarket approval submission.
Business
Character Biosciences raises $93M to advance genetics-based AMD therapeutics
Financing will support precision medicine candidates as part of its integrated patient data platform and AI-based analytics engine.
Business
Alcon purchases majority stake in Aurion Biotech
Company replaces CEO and founder Greg Kunst, gaining access to groundbreaking CED cell therapy with plans for phase 3 clinical trials expected later this year.
Business